Research News

UB to Hire Professors for New Materials Science and Engineering Graduate Program

5/7/2012


Corning Inc. developing killer glass

4/27/2012


URMC research team wins $1.9 million grant

4/26/2012

Binghamton University touts plan for energy research center

4/25/2012


URMC to open women's health center

4/25/2012


Gilead Sciences, Inc. (GILD)-Bristol-Myers Squibb Company (BMY)'s Experimental Hepatitis C Drug Cured 88% Post-Therapy

4/19/2012


Gilead Sciences, Inc. (GILD)-Bristol-Myers Squibb Company (BMY)'s Experimental Hepatitis C Drug Cured 88% Post-Therapy

4/19/2012

ESD gives UR-sponsored non-profit $2.5M

4/18/2012


AMRI, Biota to Advance Second-Generation Long-Acting Neuraminidase Inhibitor for Influenza

4/17/2012

URMC team wins $3M to lead effort to curb infections

4/17/2012


Weill Cornell Medical College Receives SU2C-PCF Prostate Dream Team Translational Cancer Research Grant

4/4/2012


New Method of Bacterial Cell Engineering Can Produce Better, Cheaper Drug Therapies

3/26/2012


Data on ELIQUIS® (apixaban) for the Prevention of Stroke in Atrial Fibrillation to Be Presented at American College of Cardiology’s 61st Annual Scientific Session

3/21/2012


UB proposes state center in materials informatics

3/18/2012


Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection

3/15/2012


URMC to partner with firm on new wound-care center

2/28/2012


Bristol-Myers Squibb and Duke Translational Medicine Institute Form Strategic Relationship to Broaden Interactions

2/28/2012


We’re #1! MatchMaestro Trophy Awarded to UR-CTSI

2/24/2012


Cornell U. Scholar to Chair URMC Department of Biostatistics

2/23/2012


Cornell University's New Storage Solution for Sequencing Data

2/23/2012


Gloria Snyder Assumes Leadership Role for Stony Brook Medicine

2/21/2012


UR joins international research network

2/17/2012


UB Works to Promote Faculty Inventions, Services

2/17/2012


UB researcher granted $2M for eye study

2/3/2012

Delving into the fathomless

2/3/2012


RIT receives grant for program supporting minority students

1/31/2012


Buffalo Faculty Member Anonymously Donates $1 Million Dollars

1/29/2012


UB research takes turn toward development

1/12/2012

National Center for Advancing Translational Sciences Established

1/6/2012

Equipment donation a boost to UB research

1/4/2012

University of Rochester recognized for outstanding volunteer enrollment in research studies

1/1/2012


Murphy Named Director of UB's New Clinical and Translational Research Center

12/29/2011

BRISK-PS Study with Investigational Compound Brivanib in Hepatocellular Carcinoma Completed

12/22/2011

Cornell Wins $100 Million Bid to Build Campus on Roosevelt Island

12/19/2011

Cancer Drugs Cure Now, May Cause Problems Later, UB Research Shows

12/16/2011

Rheonix, Inc. Announces Novel Microarray Production Technology to Support Multiplexed Endpoint Detection of Single Nucleotide Polymorphisms

12/15/2011

Cuomo signs grant for UB Medical School

12/14/2011


New Data Show Investigational Compound Dapagliflozin When Added to Glimepiride Maintained Reductions in Blood Sugar Levels in Adults with Type 2 Diabetes Over 48 Weeks of Treatment

12/8/2011

Wilmot Cancer Center, URMC get $2.6M grant

12/5/2011

URMC joins medical image exchange

12/5/2011

UR wins patent that could advance HPV vaccines

11/22/2011

Meta-Analysis of Clinical Data on Cardiovascular Safety Presented for Investigational Compound Dapagliflozin in Adult Patients with Type 2 Diabetes

11/16/2011

New Data Presented On Phase 3 Trial Of ELIQUIS® (apixaban) In The Prevention Of Venous Thromboembolism In Patients With Acute Medical Illness

11/13/2011


URMC Receives Patent for Implantable Diagnostic Technology

11/10/2011


Medtronic Begins Enrolling U.S. IDE Study of Enlite™ Sensor for Continuous Glucose Monitoring

11/9/2011


URMC wins patent on implantable biochip

11/9/2011

Wilmot Scientist Appointed to Prestigious Leadership Positions

11/8/2011


12-Week On-Treatment Results from Large Phase IIb Study (COMMAND-1) of Bristol-Myers Squibb’s NS5A Inhibitor Daclatasvir Support Anti-HCV Activity and Safety Profile Observed in Earlier Studies

11/8/2011

Phase IIIb Comparison of BARACLUDE® (entecavir) Monotherapy Versus BARACLUDE Plus Tenofovir Combination Shows No Statistical Difference Between Study Arms

11/8/2011

UB Opens Western New York’s First Memory Disorders Center

11/3/2011

URMC Launches Fundraising Campaign for New Children’s Hospital

11/2/2011


Program Launched to Examine Disease Origins in Womb, Infancy, Childhood

11/2/2011


Chemically assembled metamaterials could lead to superlenses and cloaking

11/1/2011

Carestream system gets certification

11/1/2011

New Network Will Advance Neurological Care

10/27/2011

UB Program Boosts Translational Science Throughout Buffalo Niagara Medical Campus

10/25/2011


$2.35M Grant to Improve Employment for Individuals with Disabilities

10/25/2011


Funding lift for UB pharm students

10/5/2011

$3.5M grant to fund public health project

9/29/2011

Delcath's Chemosat gives terminal cancer patients several more months of disease-free life

9/26/2011

Behling Patient Simulation Center Transforms Health Sciences Education at UB

9/20/2011

BMS-790052 Plus Peginterferon Alfa and Ribavirin Demonstrated up to 83% Sustained Virologic Response 24 Weeks Post-Treatment (SVR24) in Phase II Study of Genotype 1 Hepatitis C Patients

9/17/2011

ONGLYZA™ (saxagliptin) When Added to Insulin in Adults with Type 2 Diabetes Maintained Reductions in Blood Sugar Levels (HbA1c) Over 52 Weeks in Investigational Study Extension

9/16/2011

SU garners $3 million NSF grant for education and research in soft and biological materials

9/15/2011

Endowed gift expands The College's neuroscience program

9/14/2011

URMC lab receives $4.5 million for stem cell research

9/7/2011

BioTime Enters into Worldwide License Agreement with Cornell University

9/6/2011

Directorship of PhD Program in Translational Biomedical Science

9/2/2011

Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System

9/1/2011

Albany Business Review: UB's medical school plans to help rebuild state economy

8/30/2011

Pfizer, BMS unveil mega-blockbuster data on apixaban

8/28/2011

Back, neck pain sufferers could find relief with Cornell-developed spinal disc implants

8/1/2011

Golisano donates $20M for children's hospital at URMC

7/13/2011


University of Buffalo Wins Grant to Expand Bioinformatics Staff

7/8/2011

Syracuse University biologist discovers key regulators for biofilm development

6/24/2011


Phase II Milestone Cues Reward for AMRI

5/25/2011

Today Is:
Thursday, May 17, 2012


May Events

<< >>
SMTWTFS
12345
6789101112
13141516171819
20212223242526
2728293031